scispace - formally typeset
C

Charlotte Jeanneau

Researcher at Aix-Marseille University

Publications -  47
Citations -  2087

Charlotte Jeanneau is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Pulp (tooth) & Complement system. The author has an hindex of 21, co-authored 43 publications receiving 1684 citations. Previous affiliations of Charlotte Jeanneau include Wuhan University & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Structures and mechanisms of glycosyltransferases

TL;DR: The 3D-Glycosyltransferase database is created to gather structural information concerning this class of enzymes and to accommodate the growing number of crystal structures.
Journal ArticleDOI

Current trends in the structure-activity relationships of sialyltransferases.

TL;DR: The observed structural and functional differences strongly suggest that these two structural superfamilies have evolved independently of the canonical glycosyltransferase folds.
Journal ArticleDOI

Structural and functional features of glycosyltransferases.

TL;DR: The most recent data that provide insight into the functional organization of Golgi-resident glycosyltransferases are dealt with and new structures begin to shed light on the molecular bases accounting for donor and acceptor substrate specificities as well as catalysis.
Journal ArticleDOI

Structure-function analysis of the human sialyltransferase ST3Gal I: role of n-glycosylation and a novel conserved sialylmotif.

TL;DR: Mutational analysis showed that residues His299 and Tyr300 of the new motif, and His316 of the VS motif, are essential for activity since their substitution by alanine yielded inactive enzymes, and the invariant Tyr residue plays an important conformational role mainly attributable to the aromatic ring.
Journal ArticleDOI

Bioactivity of a Calcium Silicate–based Endodontic Cement (BioRoot RCS): Interactions with Human Periodontal Ligament Cells In Vitro

TL;DR: Preclinical results suggest that the calcium silicate cement (BioRoot RCS) has a higher bioactivity than the zinc oxide-eugenol sealer (PCS) on human PDL cells.